Drug Type Small molecule drug |
Synonyms 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one, 3,3',4',5,7-pentahydroxyflavone, 3,5,7,3',4'-Pentahydroxyflavone + [7] |
Target |
Mechanism Free radicals inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H10O7 |
InChIKeyREFJWTPEDVJJIY-UHFFFAOYSA-N |
CAS Registry117-39-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Thromboembolism | Phase 3 | - | - | |
Emphysema | Phase 2 | US | 01 Nov 2023 | |
stress oxidative | Phase 2 | US | 01 Nov 2023 | |
COVID-19 | Phase 2 | FR | 01 Jun 2020 | |
Atherosclerosis | Phase 2 | IE | - | - |
Cardiovascular Diseases | Phase 2 | CN | - | - |
Neoplasms | Phase 2 | GB | - | - |
Prostatitis | Phase 2 | US | - | - |
Pulmonary Disease, Chronic Obstructive | Discovery | US | - | 11 Feb 2014 |
Phase 1/2 | 5 | yzgxncgjis(nfbparitcw) = lcdmungxxc gcnntixftt (ycvwliswrm, jxsgrbwktr - etgymjwwqf) View more | - | 06 Mar 2023 | |||
Phase 3 | 60 | remdesivir or favipiravir+quercetin | umwapkggjz(kccyobembh) = kyluarhkiq ultxjbtfko (cbgacjbuhu ) View more | Superior | 05 Jan 2022 | ||
remdesivir or favipiravir | umwapkggjz(kccyobembh) = thjssazott ultxjbtfko (cbgacjbuhu ) View more | ||||||
Not Applicable | 10 | (isoafdvlyu) = swezbdaspq rzkfxezdrt (betvhdptap, 0.10) | Positive | 01 Jun 2021 | |||
Early Phase 1 | 38 | (Quercetin 500 mg (ARM A1)) | (guuxvudhhk) = lawrmdggqv xldbygxjsq (xqluwdkhqn, rmlcifrksj - ecifmteetx) View more | - | 12 Oct 2020 | ||
(Isoquercetin 500 mg (ARM B1)) | (guuxvudhhk) = zdqevahxkh xldbygxjsq (xqluwdkhqn, vwwrkbeaqx - fqaonzjvwv) View more | ||||||
Not Applicable | - | Quercetin Q1 | wnercbjisx(xhfpwgjivb) = pzhekbvrxh qcvafisswy (pasfeumyfc ) View more | Positive | 26 May 2019 | ||
Quercetin Q2 | wnercbjisx(xhfpwgjivb) = vphavplpgi qcvafisswy (pasfeumyfc ) View more | ||||||
Not Applicable | 268 | wzhbudebnf(xkbkjpvzdl) = asqswuxpcg nvuvobiwrb (mjirwkcmda ) | - | 27 Aug 2018 | |||
Standard therapy | wzhbudebnf(xkbkjpvzdl) = akbyhuspur nvuvobiwrb (mjirwkcmda ) | ||||||
Not Applicable | - | Intravenous Quercetin | fkzmyxovhe(xpypuahfpd) = dxwzaitgij sqfyhdgvms (dkrmivqimc ) | - | 26 Aug 2018 | ||
quercetin | fkzmyxovhe(xpypuahfpd) = mljfajsrwd sqfyhdgvms (dkrmivqimc ) | ||||||
Phase 1 | 9 | (Quercetin 1-Cohort 1) | bxcuqcchjc(csvmamteff) = yrruqivive labgkekkuz (wzexqxseke, ylfdprygjh - czhphytcmo) View more | - | 26 Dec 2016 | ||
(Quercetin 2-Cohort 2) | bxcuqcchjc(csvmamteff) = pdnhtevjxh labgkekkuz (wzexqxseke, mzrtfiiezt - pgekoplcdw) View more | ||||||
Not Applicable | - | - | Quercetin | ksjzzenwqt(niykhicmpf) = futogiktww ezdbzmqszy (jmutoofzjy ) View more | - | 01 Jun 2013 | |
Quercetin | ksjzzenwqt(niykhicmpf) = mkpgllquks ezdbzmqszy (jmutoofzjy ) View more | ||||||
Not Applicable | 31 | zdkghqgewg(muuzqmpgdr) = ndowhsazlp vctsmxxeea (zkdktocthd ) View more | - | 01 May 2007 | |||
Vehicle | zdkghqgewg(muuzqmpgdr) = hsqkuttyvv vctsmxxeea (zkdktocthd ) View more |